In brief
CSN signed a binding term sheet to sell SWT to Megasa for 550 million euros.
The sale still depends on definitive contracts.
What we know
04Transmission to assets
Market read-through
The SWT sale reinforces CSN's deleveraging plan and tends to be well received by the stock, but the value still depends on adjustments and definitive contracts.
Portfolio impact
01Proceeds reduce leverage.
Adjustments cut the value.
What would change the view: Definitive contracts signed.
Direction is an explanatory hypothesis, not a forecast or recommendation.
Next signals
What to watch
- Signing of definitive contracts
- Use of proceeds for debt
Limits of the reporting
What remains uncertain
- The value is enterprise value, not equity price.